tirzepatide farmaco a cosa serve il Tirzepatide, farmaco contro obesità e

These medications effectively slow gastric emptying, which has raised concerns regarding the risk of residual gastric volume (RGV) and potential pulmonary aspiration during procedures requiring sedation

22.67 38.62 mL, p = 0.265), or gastric volume per kilogram (GV/kg: 0.15 0.37 vs

The latter has been used for the long term management of obesity since its FDA approval several years ago

Some prescribers recommend metoclopramide (Reglan) 10mg before meals to accelerate gastric emptying, but this carries risks (tardive dyskinesia with prolonged use) and should be a last-resort option before dose reduction

In summary, tirzepatide is the first dual receptor agonist that was recently approved for the treatment of T2D by the FDA

People most often get semaglutide as an injection